Wear it pink this October Wear pink. Raise money. Help make life-changing breast cancer research and support happen.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 209 results Fantastic outcome for certain patients with incurable secondary triple negative breast cancer as pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) is approved for use on the NHS in Scotland 10 Oct 2022 1 min read We welcome approval of palbociclib with fulvestrant for routine use on the NHS 23 Sept 2022 1 min read We respond to research about breast cancer surgery margins 22 Sept 2022 1 min read We respond to research about physical activity and breast cancer risk 07 Sept 2022 1 min read Breast Cancer Now responds to the HSJ and BBC Newsnight's joint special investigation about long cancer waits 11 Aug 2022 1 min read We respond to MP Dawn Butler's mission to find the Million Missing Mammograms 02 Aug 2022 1 min read Breast Cancer Now welcomes NICE decision to recommend alpelisib with fulvestrant for routine use on the NHS 14 Jul 2022 2 min read Breast Cancer Now celebrates landmark victory as Trodelvy is recommended for use on the NHS in England 14 Jul 2022 2 min read We respond to the approval of breast cancer drug abemaciclib for routine use on the NHS 17 Jun 2022 2 min read We respond to research that suggests drugs that neutralise progesterone activity could be a potential risk-reducing treatment for women with altered BRCA genes 15 Jun 2022 1 min read We respond to the Royal College of Radiologists’ clinical radiology and clinical oncology census reports for 2021 10 Jun 2022 1 min read We respond to new findings from the Lumina trial which suggest some patients could avoid radiotherapy 07 Jun 2022 1 min read Previous 1 ... 11 ... 18 Next
Fantastic outcome for certain patients with incurable secondary triple negative breast cancer as pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) is approved for use on the NHS in Scotland 10 Oct 2022 1 min read
We welcome approval of palbociclib with fulvestrant for routine use on the NHS 23 Sept 2022 1 min read
Breast Cancer Now responds to the HSJ and BBC Newsnight's joint special investigation about long cancer waits 11 Aug 2022 1 min read
Breast Cancer Now welcomes NICE decision to recommend alpelisib with fulvestrant for routine use on the NHS 14 Jul 2022 2 min read
Breast Cancer Now celebrates landmark victory as Trodelvy is recommended for use on the NHS in England 14 Jul 2022 2 min read
We respond to the approval of breast cancer drug abemaciclib for routine use on the NHS 17 Jun 2022 2 min read
We respond to research that suggests drugs that neutralise progesterone activity could be a potential risk-reducing treatment for women with altered BRCA genes 15 Jun 2022 1 min read
We respond to the Royal College of Radiologists’ clinical radiology and clinical oncology census reports for 2021 10 Jun 2022 1 min read
We respond to new findings from the Lumina trial which suggest some patients could avoid radiotherapy 07 Jun 2022 1 min read
